Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sander I van Leuven
Mycophenolate Mofetil but Not Atorvastatin Attenuates Atherosclerosis in Lupus-Prone LDLr−/−mice
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Mycophenolate Mofetil Reduces STAT3 Phosphorylation in Systemic Lupus Erythematosus Patients
JCI insight
Medicine
Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis
Kidney International
Nephrology
Lack of Tyrosylprotein Sulfotransferase Activity in Hematopoietic Cells Drastically Attenuates Atherosclerosis in LDLR-/- Mice
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE−/− Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
PLoS ONE
Multidisciplinary
Mycophenolate Mofetil Prevents a Clinical Relapse in Patients With Systemic Lupus Erythematosus at Risk
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Ces3/TGH Deficiency Improves Dyslipidemia and Reduces Atherosclerosis in LDLR-/- Mice
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Childhood-Onset Proliferative Lupus Nephritis
Arthritis Care and Research
Rheumatology
Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-Onset Lupus Nephritis
Lupus
Rheumatology
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
